DETAILS, FICTION AND ABBV-744 IN ACUTE MYELOID LEUKEMIA (AML)

In Section A, members will obtain distinct doses and schedules of oral ABBV-744 pill to detect Harmless dosing routine. Further participants will be enrolled on the identified monotherapy dosign routine. In Segment B, contributors will obtain oral ruxolitinib and ABBV-744 will probably be given as "insert-on" therapy. In Segment C, members will rec